GALMED PHARMACEUTICALS LTD (GLMD) Stock Income Statement
NASDAQ:GLMD - IL0011313900 - Common Stock
1.39 USD
-0.02 (-1.42%)
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 6.14M | 6.27M | 7.49M | 17.65M | 32.88M | |||
| Research and Development | 2.98M | N/A | 3.57M | 13.00M | 27.22M | |||
| Selling, General, and Administrative Expenses | 3.17M | 3.30M | 3.92M | 4.66M | 5.66M | |||
| Operating Income | -6.14M | -6.27M | -7.49M | -17.65M | -32.88M | |||
| Interest Income/Expense | -60.00K | N/A | 591.00K | -190.00K | 460.00K | |||
| Other Income/Expense | N/A | -20.00K | -10.00K | -20.00K | -40.00K | |||
| Non Recurring Items | N/A | -1.15M | N/A | N/A | N/A | |||
| Income Before Taxes | -7.35M | -7.52M | -6.91M | -17.87M | -32.47M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -7.35M | -7.52M | -6.91M | -17.87M | -32.47M | |||
| EBITDA | N/A | -6.19M | -7.46M | -17.61M | -32.84M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -7.07 | -8.08 | -30.04 | -10.63 | -19.80 | |||
| Non GAAP EPS | N/A | N/A | -39.12 | -126.00 | -237.60 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD